rs2896526
Variant names: 
Your query was ambiguous. Multiple possible variants found: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_005566.4(LDHA):c.127-1172A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.146 in 152,110 control chromosomes in the GnomAD database, including 1,723 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.15   (  1723   hom.,  cov: 33) 
Consequence
 LDHA
NM_005566.4 intron
NM_005566.4 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  -0.692  
Publications
25 publications found 
Genes affected
 LDHA  (HGNC:6535):  (lactate dehydrogenase A) This gene encodes the A subunit of lactate dehydrogenase enzyme which catalyzes the reversible conversion of pyruvate to lactate with the concomitant oxidation of NADH to NAD in anaerobic glycolysis. The protein is found predominantly in skeletal muscle and belongs to the lactate dehydrogenase family. Mutations in this gene have been linked to exertional myoglobinuria. The human genome contains several non-transcribed pseudogenes of this gene. [provided by RefSeq, Sep 2023] 
LDHA Gene-Disease associations (from GenCC):
- glycogen storage disease due to lactate dehydrogenase M-subunit deficiencyInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77). 
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.165  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.146  AC: 22138AN: 151992Hom.:  1722  Cov.: 33 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
22138
AN: 
151992
Hom.: 
Cov.: 
33
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome   AF:  0.146  AC: 22140AN: 152110Hom.:  1723  Cov.: 33 AF XY:  0.143  AC XY: 10634AN XY: 74356 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
22140
AN: 
152110
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
10634
AN XY: 
74356
show subpopulations 
African (AFR) 
 AF: 
AC: 
4906
AN: 
41488
American (AMR) 
 AF: 
AC: 
2554
AN: 
15268
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
520
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
340
AN: 
5180
South Asian (SAS) 
 AF: 
AC: 
689
AN: 
4824
European-Finnish (FIN) 
 AF: 
AC: 
1210
AN: 
10560
Middle Eastern (MID) 
 AF: 
AC: 
67
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
11410
AN: 
68000
Other (OTH) 
 AF: 
AC: 
344
AN: 
2112
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.502 
Heterozygous variant carriers
 0 
 983 
 1967 
 2950 
 3934 
 4917 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 252 
 504 
 756 
 1008 
 1260 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.